BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6298933)

  • 1. [Treatment of reflux esophagitis with ranitidine. A multicentric prospective study].
    Koelz HR; Birchler R; Bron B; Delmore G; Frey M; Gonvers JJ; Halter F; Hammer B; Miller G; Realini S; Blum AL
    Schweiz Med Wochenschr; 1982 Dec; 112(51):1901-4. PubMed ID: 6298933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranitidine vs metoclopramide in the medical treatment of reflux esophagitis.
    Guslandi M; Testoni PA; Passaretti S; Masci E; Ballarin E; Comin U; Marchi R; Ronchi G; Tittobello A
    Hepatogastroenterology; 1983 Jun; 30(3):96-8. PubMed ID: 6309637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of roxatidine acetate and ranitidine in the treatment of reflux esophagitis. The Roxatidine Esophagitis Study Group.
    Clin Ther; 1993; 15(2):283-93. PubMed ID: 8100189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cimetidine versus ranitidine in the treatment of peptic esophagitis].
    Noya G; Dettori G; Muscas A; Spirito R; Niolu P; Marongiu G; Biglioli P
    Minerva Med; 1983 Apr; 74(14-15):787-90. PubMed ID: 6132354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
    Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic factors influencing healing of reflux esophagitis. A controlled trial of omeprazole versus ranitidine. Study group Omega].
    Barbier JP; Haccoun P; Bergmann JF; Arnould B; Hamelin B
    Ann Gastroenterol Hepatol (Paris); 1993; 29(4):213-8. PubMed ID: 8239492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
    Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
    Pfefferkorn MD; Croffie JM; Gupta SK; Molleston JP; Eckert GJ; Corkins MR; Fitzgerald JF
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
    McKenna CJ; Mills JG; Goodwin C; Wood JR
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisapride versus ranitidine in the treatment of reflux esophagitis.
    Janisch HD; Hüttemann W; Bouzo MH
    Hepatogastroenterology; 1988 Jun; 35(3):125-7. PubMed ID: 3042576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reflux esophagitis: therapy with H2-blockers, and motility disorders].
    Pace F; Sangaletti O; Zhu H; Bianchi Porro G
    Minerva Chir; 1991 Apr; 46(7 Suppl):163-7. PubMed ID: 2067675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of gastrosidine (famotidine) in the treatment of gastroesophageal reflux at the reflux esophagitis stage].
    Vasil'ev IuV; Li IA
    Eksp Klin Gastroenterol; 2002; (4):30-3, 131. PubMed ID: 12503271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [2 or 1 daily doses of ranitidine in the treatment of reflux esophagitis].
    Rohner HG; Wienbeck M
    Z Gastroenterol; 1986 Aug; 24(8):396-402. PubMed ID: 3532593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cimetidine and ranitidine in the treatment of reflux esophagitis].
    Kimmig JM
    Z Gastroenterol; 1984 Aug; 22(8):373-8. PubMed ID: 6091353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind crossover study of ranitidine and ebrotidine in gastro-esophageal reflux disease.
    Sito E; Thor PJ; M[aczka M; Lorens K; Konturek SJ; Maj A
    J Physiol Pharmacol; 1993 Sep; 44(3):259-72. PubMed ID: 8241527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of reflux oesophagitis.
    Wesdorp IC
    Scand J Gastroenterol Suppl; 1982; 79():106-19. PubMed ID: 6131532
    [No Abstract]   [Full Text] [Related]  

  • 20. [A randomized, comparative study of rabeprazole vs. ranitidine maintenance therapies for reflux esophagitis--multicenter study].
    Jee SR; Seol SY; Kim DH; Park SJ; Han SY; Urm SH; Lee JT
    Korean J Gastroenterol; 2005 May; 45(5):321-7. PubMed ID: 15908764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.